ORCL vs TCRX · P/E 31, rev $67.36B vs rev $2.0M
Oracle Corporation (ORCL) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Michael D. Sicilia.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
ORCL currently screens at market cap $527.84B and trailing P/E 31.4. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the ORCL and TCRX stock pages for the full models.
Not investment advice.